Phase 2 Trial of Pemetrexed (Alimta) Combined With Paclitaxel in Patients With Recurrent/Advanced Follicular, Papillary or Anaplastic Thyroid Cancer.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Paclitaxel; Pemetrexed
- Indications Thyroid cancer
- Focus Therapeutic Use
- Acronyms Panthera
- 26 May 2012 Company added in the association field as reported by EudraCT.
- 18 Jan 2011 Planned end date changed from 1 Nov 2011 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 24 Nov 2008 New trial record.